...
首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: Secondary prevention of small subcortical strokes trial
【24h】

Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: Secondary prevention of small subcortical strokes trial

机译:最近腔隙性脑卒中患者脑卒中复发的预测指标以及根据风险状况对干预措施的反应:小皮层下卒中的二级预防试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Among participants in the Secondary Prevention of Small Subcortical Strokes randomized trial, we sought to identify patients with high versus low rates of recurrent ischemic stroke and to assess effects of aggressive blood pressure control and dual antiplatelet therapy according to risk status. Methods Multivariable analyses of 3020 participants with recent magnetic resonance imaging-defined lacunar strokes followed for a mean of 3.7 years with 243 recurrent ischemic strokes. Results Prior symptomatic lacunar stroke or transient ischemic attack (TIA) (hazard ratio [HR] 2.2, 95% confidence interval [CI] 1.6, 2.9), diabetes (HR 2.0, 95% CI 1.5, 2.5), black race (HR 1.7, 95% CI 1.3, 2.3), and male sex (HR 1.5, 95% CI 1.1, 1.9) were each independently predictive of recurrent ischemic stroke. Recurrent ischemic stroke occurred at a rate of 4.3% per year (95% CI 3.4, 5.5) in patients with prior symptomatic lacunar stroke or TIA (15% of the cohort), 3.1% per year (95% CI 2.6, 3.9) in those with more than 1 of the other 3 risk factors (27% of the cohort), and 1.3% per year (95% CI 1.0, 1.7) in those with 0-1 risk factors (58% of the cohort). There were no significant interactions between treatment effects and stroke risk status. Conclusions In this large, carefully followed cohort of patients with recent lacunar stroke and aggressive blood pressure management, prior symptomatic lacunar ischemia, diabetes, black race, and male sex independently predicted ischemic stroke recurrence. The effects of blood pressure targets and dual antiplatelet therapy were similar across the spectrum of independent risk factors and recurrence risk.
机译:背景:在“小皮质下卒中二级预防”随机试验的参与者中,我们试图确定反复缺血性卒中发生率高与低的患者,并根据风险状况评估积极控制血压和双重抗血小板治疗的效果。方法对3020名最近经磁共振成像定义的腔隙性卒中的患者进行多变量分析,平均3.7年,发生243次复发性缺血性卒中。结果先前的症状性腔隙性脑卒中或短暂性脑缺血发作(TIA)(危险比[HR] 2.2、95%置信区间[CI] 1.6、2.9),糖尿病(HR 2.0、95%CI 1.5、2.5),黑人(HR 1.7) ,95%CI 1.3、2.3)和男性(HR 1.5、95%CI 1.1、1.9)分别预测缺血性卒中的复发。先前有症状性腔隙性脑卒中或TIA的患者(占队列的15%),每年复发性缺血性卒中的发生率为4.3%(95%CI 3.4,5.5),每年为3.1%(95%CI 2.6,3.9)。那些具有其他3个危险因素中的1个以上(占队列的27%)的人,每年有1.3个比率(95%的CI 1.0,1.7)在具有0-1个危险因素的人群中(占队列的58%)。治疗效果和中风风险状态之间没有显着的相互作用。结论在大量近期接受腔隙性卒中和积极控制血压的患者队列中,先前有症状的腔隙性缺血,糖尿病,黑人种族和男性患者独立预测缺血性卒中的复发。在独立危险因素和复发风险的范围内,血压目标和双重抗血小板治疗的作用相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号